Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Videos [1837]

Fulvestrant versus anastrozole in patients with advanced breast cancer

Prof John Robertson - Royal Derby Hospital, Derby, UK

Fulvestrant versus anastrozole in patients with advanced breast cancer ( Prof John Robertson - Royal Derby Hospital, Derby, UK )

Reducing fat intake reduces death rates in some breast cancer patients

Professor Rowan Chlebowski - Harbor-UCLA Medical Centre, Torrance, USA

Reducing fat intake reduces death rates in some breast cancer patients ( Professor Rowan Chlebowski - Harbor-UCLA Medical Centre, Torrance, USA )

Recurrence risk could be predicted by a multigene test in ductal carcinoma...

Prof Eileen Rakovitch - Sunnybrook Research Institute, Toronto, Canada

Recurrence risk could be predicted by a multigene test in ductal carcinoma breast cancer ( Prof Eileen Rakovitch - Sunnybrook Research Institute, Toronto, Canada )

Breast cancer in men and women has different biological characteristics and...

Dr Fatima Cardoso - Champalimaud Cancer Center, Lisbon, Portugal

Breast cancer in men and women has different biological characteristics and outcomes ( Dr Fatima Cardoso - Champalimaud Cancer Center, Lisbon, Portugal )

PD-1 inhibitor pembrolizumab shows promising clinical activity for triple...

Dr Rita Nanda - University of Chicago Medicine, Chicago, USA

PD-1 inhibitor pembrolizumab shows promising clinical activity for triple-negative breast cancer ( Dr Rita Nanda - University of Chicago Medicine, Chicago, USA )

Magnetic nanotechnology for the localisation of non-palpable breast cancers and...

Dr Muneer Ahmed - Guys Hospital, London, UK

Magnetic nanotechnology for the localisation of non-palpable breast cancers and concurrent sentinel node biopsy ( Dr Muneer Ahmed - Guys Hospital, London, UK )

Combination of eribulin and capecitabine provides clinical benefit for women...

Dr Chris Twelves - St James's Hospital, Leeds, UK

Combination of eribulin and capecitabine provides clinical benefit for women with metastatic breast cancer ( Dr Chris Twelves - St James's Hospital, Leeds, UK )

Ovarian suppression with tamoxifen reduced recurrence for some women with...

Dr Prudence Francis - Peter MacCallum Cancer Centre, Melbourne, Australia

Ovarian suppression with tamoxifen reduced recurrence for some women with premenopausal breast cancer ( Dr Prudence Francis - Peter MacCallum Cancer Centre, Melbourne, Australia )

Comment: Impact of combined bevacizumab and presurgery chemo varies by subtype

Prof Carlos Arteaga - Vanderbilt-Ingram Cancer Center, Nashville, USA

Comment: Impact of combined bevacizumab and presurgery chemo varies by subtype ( Prof Carlos Arteaga - Vanderbilt-Ingram Cancer Center, Nashville, USA )

Adding ultrasound to routine mammography improves cancer detection in dense...

Dr Jean Weigert - Cancer Center of Central Connecticut, New Britain, USA

Adding ultrasound to routine mammography improves cancer detection in dense breasts ( Dr Jean Weigert - Cancer Center of Central Connecticut, New Britain, USA )

High tumour immune cell levels may help screen HER2-positive breast cancer...

Dr Edith Perez - Mayo Clinic, Rochester, USA

High tumour immune cell levels may help screen HER2-positive breast cancer patients for chemo ( Dr Edith Perez - Mayo Clinic, Rochester, USA )

Comment: Combining tamoxifen with ovarian suppression reduced recurrence of...

Prof Carlos Arteaga - Vanderbilt-Ingram Cancer Center, Nashville, USA

Comment: Combining tamoxifen with ovarian suppression reduced recurrence of some breast cancers ( Prof Carlos Arteaga - Vanderbilt-Ingram Cancer Center, Nashville, USA )

More from ecancer